WHO has listed the first two diagnostic tests for emergency use during the Covid 19 pandemic The move should help increase access to quality assured accurate tests for the disease It also means that the tests can now be supplied by the United Nations and other procurement agencies supporting the COVID 19 response Both in vitro diagnostics the tests are genesig Real Time PCR Coronavirus COVID 19 and cobas SARS CoV 2 Qualitative assay for use on the cobas 6800 8800 Systems The emergency use listing of these products will enable countries to increase testing with quality assured diagnostics says Dr Mari ngela Sim o WHO Assistant Director General for Medicines and Health Products Facilitating access to accurate tests is essential for countries to address the pandemic with the best tools possible The Emergency Use Listing procedure EUL was established to expedite the availability of diagnostics needed in public health emergency situations It is intended to help procurement agencies and countries navigate the large presence of different devices on the market and by assessing them provides assurance of the products quality and performance The genesig Real Time PCR Coronavirus COVID 19 Primerdesign United Kingdom is an open system more suitable for laboratories with moderate sample testing capacity while the cobas SARS CoV 2 for use on the cobas 6800 8800 Systems Roche United States of America is a closed system assay for larger laboratories EUL listed products https www who int diagnostics laboratory 200407 eul sars cov2 product list pdf ua 1 Roche test https www who int diagnostics laboratory eul 0504 046 00 cobas sars cov2 qualitative assay ifu pdf ua 1 Primerdesign test https www who int diagnostics laboratory eul 0489 185 00 path covid19 ce ivd ifu issue 2 0 pdf ua 1